21.5203.67% ( -0.820 )
Delay Closed: Nov 17, 16:08:15Valuation
Current ValuationThe current P/E ratio is 8.39, below the reasonable range, cheaper than 99.51% of the time in the past 1 years, and the industry ranks 6/21, the industry Median 8.72.
8.39xP/E
HK$21.52Stock price
HK$2.56Earnings per share
8.39xP/E
Stock priceHK$21.52Earnings per shareHK$2.56
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 11.00x
- Typical range
- 9.06x–15.56x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 8.72x
023466992
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 8.72x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
01515HKCR MEDICAL | 6.63x | 6.49% | HK$3.22B |
02219HKCHAOJU EYE CARE | 8.72x | 18.06% | HK$1.65B |
02677HKDISTINCT HEALTH | 8.39x | -- | HK$1.39B |
01526HKRICI HEALTH | 3.71x | -- | HK$1.27B |
02279HKYONGHE MEDICAL | 8.29x | 49.38% | HK$1.16B |
03689HKKANGHUA HEALTH | 5.43x | -- | HK$601.91M |
02135HKRAILY AESMED | 3.39x | -- | HK$52.92M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
